This resource is essential for helping patients master the three pillars of a successful weight loss journey: meal pattern, meal composition, and hydration
In recent years, there has been a significant increase in the use and prescription of glucagon-like peptide-1 receptor agonists (GLP-1RA), a class of medications commonly prescribeGLP-1RAGLP-1RAd for type 2 diabetes and obesity
Investigation of combination therapies pairing incretin-based agents with other mechanistically distinct therapies may yield additive or synergistic benefits [71]
Additionally, 156 pregnant women with a diagnosis of diabetes mellitus and 163 pregnant overweight or obese were included in two distinct reference groups
If orforglipron can be manufactured at scale for a fraction of the cost of injectable alternatives, and if its oral format eliminates the injection barriers that prevent millions from starting therapy, the public health impact could be measured in reduced cardiovascular events, fewer diabetes-related amputations, decreased obesity-related cancer incidence, and extended healthy lifespan across populations
Yes, for type 2 diabetes
